FCGR3A and neoplasm: Concordantly, a V158F single nucleotide polymorphism (SNP) (rs396991) of FCGR3A (encoding FcγRIIIA) was associated with improved ORR and OS in ipilimumab‐treated melanoma cohorts, specifically for those tumours with higher insertion–deletion (indel) burden [56].